EFSA J. 2019 Nov 26;17(11):e05908. doi: 10.2903/j.efsa.2019.5908. eCollection 2019 Nov.
In July 2019, the European Commission asked EFSA to provide a statement on the available outcomes of the human health assessment in the context of the pesticides peer review for the renewal of approval of the active substance chlorpyrifos-methyl conducted in accordance with Commission Implementing Regulation (EC) No 844/2012. Accordingly, EFSA delivered a statement to the Commission providing a summary of the main findings of the assessment related to human health following the pesticides peer review expert discussions in mammalian toxicology held between 1 and 5 April 2019, as well as EFSA's additional considerations, including whether the active substance can be expected to meet the approval criteria applicable to human health as laid down in Article 4 of Regulation (EC) No 1107/2009. A follow-up mandate was received to update the statement issued on 31 July 2019 with the outcome of the expert meeting in mammalian toxicology held on 5 September 2019 during which chlorpyrifos-methyl was rediscussed. The concerns identified in the previous statement are maintained.
2019年7月，欧盟委员会要求欧洲食品安全局就按照委员会实施条例（EC）No 844/2012对活性物质甲基毒死蜱重新批准进行的农药同行评审中人类健康评估的现有结果发表声明。据此，欧洲食品安全局向委员会提交了一份声明，概述了2019年4月1日至5日举行的哺乳动物毒理学农药同行评审专家讨论后与人类健康相关的评估主要结果，以及欧洲食品安全局的其他考虑因素，包括该活性物质是否有望符合（EC）No 1107/2009号条例第4条规定的适用于人类健康的批准标准。收到了一项后续任务授权，用2019年9月5日举行的哺乳动物毒理学专家会议结果更新2019年7月31日发布的声明，该会议期间重新讨论了甲基毒死蜱。先前声明中确定的问题仍然存在。
